Lista de obras - Arturo Reyes-Sandoval - Dominio Público Uruguay

A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease

scientific article published on 12 November 2019

A Zika vaccine based on chimpanzee adenovirus ChAdOx1 elicits lineage-transcending sterile immunity and prevents colonisation of brain and ovaries

scholarly article published 14 January 2019

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP

A probabilistic model of pre-erythrocytic malaria vaccine combination in mice

artículo científico publicado en 2019

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection

artículo científico publicado en 2019

Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand

artículo científico publicado en 2015

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

artículo científico publicado en 2007

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

artículo científico publicado en 2017

Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.

artículo científico publicado en 2005

CD8+ T effector memory cells protect against liver-stage malaria

artículo científico publicado en 2011

Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus ⬇️

artículo científico publicado el 1 de agosto de 2003

Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells-Comparison of Their Performances in ELISA

artículo científico publicado en 2020

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites

artículo científico publicado en 2018

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

artículo científico publicado en 2012

Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention

scientific article published on 03 December 2019

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses

artículo científico publicado en 2004

DNA vaccines

artículo científico publicado en 2001

Detecting circulating antibodies by controlled surface modification with specific target proteins: Application to malaria

artículo científico publicado en 2017

Development of a Plasmodium vivax malaria vaccine for clinical applications using transgenic parasites, virus-like particles and recombinant viruses

artículo científico publicado en 2014

Development of novel vaccine candidates and challenge models for Plasmodium vivax

artículo científico publicado en 2014

Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform

scientific article published on 08 October 2020

Dissection-independent production of <i>Plasmodium</i> sporozoites from whole mosquitoes

artículo científico publicado en 2021

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection

scientific article published on 17 April 2020

Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites

artículo científico publicado en 2013

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates

artículo científico publicado en 2020

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine

scientific article published on 08 February 2017

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques

artículo científico publicado en 2013

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

artículo científico publicado en 2004

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates

artículo científico publicado en 2010

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines

scientific article published on 16 June 2020

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice

artículo científico publicado en 2013

Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles

artículo científico publicado en 2016

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses

artículo científico publicado en 2016

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination

scientific article published on 11 March 2021

Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria

artículo científico publicado en 2008

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity

artículo científico publicado en 2012

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

artículo científico publicado en 2002

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection

artículo científico publicado en 2012

Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region

article

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier ⬇️

artículo científico publicado el 1 de octubre de 2003

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+T-Cell Responses

article

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses

artículo científico publicado en 2009

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge

artículo científico publicado en 2018

Prime-boost vectored malaria vaccines: progress and prospects

artículo científico publicado en 2010

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

artículo científico publicado en 2013

Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

scientific article published on 03 May 2019

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.

artículo científico publicado en 2018

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models

artículo científico publicado en 2017

Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon

artículo científico publicado en 2020

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

artículo científico publicado en 2008

Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A

artículo científico publicado en 2008

Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses

artículo científico publicado en 2012

Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine

artículo científico publicado en 2012

Tailoring a Combination Preerythrocytic Malaria Vaccine

artículo científico publicado en 2015

Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors

scientific article published in 2018

The importance of the immunodominant CD8+ T cell epitope of Plasmodium berghei circumsporozoite protein in parasite- and vaccine-induced protection

artículo científico publicado en 2020

Transient IL-10 receptor blockade can enhance CD8(+) T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen

artículo científico publicado en 2015

Viral vector vaccines make memory T cells against malaria.

artículo científico publicado en 2007

Viral vectors as vaccine platforms: deployment in sight

artículo científico publicado en 2011

Lista de obras de Arturo Reyes-Sandoval

A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease

A Zika vaccine based on chimpanzee adenovirus ChAdOx1 elicits lineage-transcending sterile immunity and prevents colonisation of brain and ovaries

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP

A probabilistic model of pre-erythrocytic malaria vaccine combination in mice

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection

Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.

CD8+ T effector memory cells protect against liver-stage malaria

Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus ⬇️

Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells-Comparison of Their Performances in ELISA

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses

DNA vaccines

Detecting circulating antibodies by controlled surface modification with specific target proteins: Application to malaria

Development of a Plasmodium vivax malaria vaccine for clinical applications using transgenic parasites, virus-like particles and recombinant viruses

Development of novel vaccine candidates and challenge models for Plasmodium vivax

Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform

Dissection-independent production of <i>Plasmodium</i> sporozoites from whole mosquitoes

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection

Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice

Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination

Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection

Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier ⬇️

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+T-Cell Responses

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge

Prime-boost vectored malaria vaccines: progress and prospects

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models

Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A

Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses

Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine

Tailoring a Combination Preerythrocytic Malaria Vaccine

Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors

The importance of the immunodominant CD8+ T cell epitope of Plasmodium berghei circumsporozoite protein in parasite- and vaccine-induced protection

Transient IL-10 receptor blockade can enhance CD8(+) T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen

Viral vector vaccines make memory T cells against malaria.

Viral vectors as vaccine platforms: deployment in sight